People on the Move
Parexel
With a background in oncology drug development, Dr. Bob (Bhardwaj) Desai, has been named vice president of consulting, technical (oncology), at Parexel.
“In my role I am planning to help many global companies by providing scientific clinical development plans and regulatory strategies that will allow them to advance innovative new treatments from bench to bedside, and ultimately meet our common goal of conquering cancer,” he told us.
Desai has led global oncology and biologic/biosimilar drug development programs for Astellas Oncology, Pfizer, Hospira, and Abbott/Abbvie.